November 7, 2013
Customizing Individualized Medicine Using Tumor Genomics To Fight Prostate Cancer
By AJ Montpetit
Researchers at Mayo Clinic, and the Center for Individualized Medicine, have recently been utilizing genomic sequencing to help develop personalized care treatments for men with castration-resistant prostate cancer, a progressive and incurable stage of prostate cancer that no longer responds to hormone therapies that stop or slow testosterone production. “Men with castration-resistant prostate cancer have abysmal […]
Tags: center for individualized medicine, genome, genomics, Gianrico Farrugia, individualized medicine, Manish Kohli, mayo clinic, personalized care, personalized medicine, PROMOTE, Prostate Cancer, Prostate Cancer Medically Optimized Genome-Enhanced Therapy
October 22, 2013
Understanding Prostate Cancer, One Man At A Time
By AJ Montpetit
The Prostate Cancer Medically Optimized Genome-Enhanced Therapy (PROMOTE) study uses genetic clues in castration-resistant prostate cancer (CPRC) that may identify an individualized treatment approach for men with the disease. Those with advanced prostate cancer can have tumors resistant to standard hormone treatments that lower testosterone. Our goal is to improve treatments by using genetic sequencing to uncover […]
Tags: Biopsy, cancer, castration resistent prostate cancer, castration-resistant prostate cancer, center for individualized medicine, CRPC, DNA, DNA Sequencing, genetic, Genetic Counseling, Genetic Sequencing, Genetics